337 related articles for article (PubMed ID: 32707720)
1. Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer.
Kato S; Honda K
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707720
[TBL] [Abstract][Full Text] [Related]
2. Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.
Honda K; Srivastava S
Biomark Med; 2016 Nov; 10(11):1197-1207. PubMed ID: 27673558
[TBL] [Abstract][Full Text] [Related]
3. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
4. New developments in the early diagnosis of pancreatic cancer.
Zhang Q; Chen S; Zeng L; Chen Y; Lian G; Qian C; Li J; Xie R; Huang KH
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):149-156. PubMed ID: 27937041
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
6. [Early stage pancreatic cancer].
Kahlert C; Distler M; Aust D; Gieldon L; Weitz J; Welsch T
Chirurg; 2018 Apr; 89(4):257-265. PubMed ID: 29264630
[TBL] [Abstract][Full Text] [Related]
7. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities.
Farr KP; Moses D; Haghighi KS; Phillips PA; Hillenbrand CM; Chua BH
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626142
[TBL] [Abstract][Full Text] [Related]
8. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Zhang X; Shi S; Zhang B; Ni Q; Yu X; Xu J
Am J Cancer Res; 2018; 8(3):332-353. PubMed ID: 29636993
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: early detection, diagnosis, and screening.
Suzuki R; Ohira H; Irisawa A; Bhutani MS
Clin J Gastroenterol; 2012 Oct; 5(5):322-6. PubMed ID: 26181069
[TBL] [Abstract][Full Text] [Related]
10. Advance in microRNA as a potential biomarker for early detection of pancreatic cancer.
Huang J; Liu J; Chen-Xiao K; Zhang X; Lee WN; Go VL; Xiao GG
Biomark Res; 2016; 4():20. PubMed ID: 27795830
[TBL] [Abstract][Full Text] [Related]
11. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.
Moravec R; Divi R; Verma M
World J Gastrointest Oncol; 2017 Jun; 9(6):235-250. PubMed ID: 28656074
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms.
Honda K
Cancer Biomark; 2022; 33(4):503-512. PubMed ID: 35491769
[TBL] [Abstract][Full Text] [Related]
13. [Precancerous conditions and risk factors for pancreatic and bile duct cancer].
Novotný I
Klin Onkol; 2013; 26 Suppl():S29-33. PubMed ID: 24325160
[TBL] [Abstract][Full Text] [Related]
14. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.
Mohammed A; Janakiram NB; Lightfoot S; Gali H; Vibhudutta A; Rao CV
Curr Med Chem; 2012; 19(22):3701-13. PubMed ID: 22680929
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.
Xue J; Jia E; Ren N; Lindsay A; Yu H
Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495
[TBL] [Abstract][Full Text] [Related]
16. New Insight into the Role of Exosomes in Pancreatic Cancer.
Wang CC; Zhao YM; Wang HY; Zhao YP
Ann Clin Lab Sci; 2019 May; 49(3):385-392. PubMed ID: 31308040
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
[TBL] [Abstract][Full Text] [Related]
18. Early detection of pancreatic cancer: why, who, and how to screen.
Klapman J; Malafa MP
Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
[TBL] [Abstract][Full Text] [Related]
19. Risk factors, biomarker and imaging techniques used for pancreatic cancer screening.
Thomas C
Chin Clin Oncol; 2017 Dec; 6(6):61. PubMed ID: 29307201
[TBL] [Abstract][Full Text] [Related]
20. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
